Phosphorylation: Implications in Cancer
- 20 January 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Protein Chemistry
- Vol. 36 (1), 1-6
- https://doi.org/10.1007/s10930-017-9696-z
Abstract
Post translational modifications (PTMs) are involved in variety of cellular activities and phosphorylation is one of the most extensively studied PTM, which regulates a number of cellular functions like cell growth, differentiation, apoptosis and cell signaling in healthy condition. However, alterations in phosphorylation pathways result in serious outcomes in the form of diseases, especially cancer. Many signalling pathways including Tyrosine kinase, MAP kinase, Cadherin-catenin complex, Cyclin-dependent kinase etc. are major players of the cell cycle and deregulation in their phosphorylation-dephosphorylation cascade has been shown to be manifested in the form of various types of cancers. Tyrosine kinase family encompasses the greatest number of oncoproteins. MAPK cascade has an importance role in cancer growth and progression. Bcl-2 family proteins serve either proapoptotic or antiapoptotic function. Cadherin-catenin complex regulates cell adhesion properties and cyclins are the key regulators of cell cycle. Altered phosphorylations in any of the above pathways are strongly associated with cancer, at the same time they serve as the potential tergets for drug development against cancer. Drugs targeting tyrosine kinase are potent anticancer drugs. Inhibitors of MEK, PI3K and ERK signalling pathways are undergoing clinical trials. Thus, drugs targeting phosphorylation pathways represent a promising area for cancer therapy.Keywords
This publication has 62 references indexed in Scilit:
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- Gain and loss of phosphorylation sites in human cancerBioinformatics, 2008
- Mechanisms of specificity in protein phosphorylationNature Reviews Molecular Cell Biology, 2007
- Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1Oncogene, 2006
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV ResponseMolecular Cell, 2003
- Beyond Herceptin and GleevecCurrent Opinion in Chemical Biology, 2003
- Differential Phosphorylation of the Signal-responsive Domain of IκBα and IκBβ by IκB KinasesOnline Journal of Public Health Informatics, 2003
- The origins of protein phosphorylationNature, 2002
- The Hallmarks of CancerCell, 2000